Granules Pharmaceuticals Receives FDA Tentative Approval with 180-Day Exclusivity for Generic gDYANAVEL XR Tablets
Mumbai: Granules Pharmaceuticals, Inc., a wholly owned subsidiary of Granules India Limited, has received Tentative Approval from the U.S. Food
Read More